IRIS
LANIA, Andrea Gerardo Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.688
EU - Europa 1.151
AS - Asia 593
AF - Africa 192
SA - Sud America 19
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.656
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.670
FI - Finlandia 336
SG - Singapore 320
IE - Irlanda 236
NG - Nigeria 191
CN - Cina 182
FR - Francia 122
DE - Germania 106
IT - Italia 87
NL - Olanda 79
GB - Regno Unito 52
IN - India 42
SE - Svezia 41
MK - Macedonia 16
BE - Belgio 15
PK - Pakistan 15
RU - Federazione Russa 15
CA - Canada 14
CL - Cile 10
IL - Israele 9
TR - Turchia 9
UA - Ucraina 9
AU - Australia 7
CH - Svizzera 6
HU - Ungheria 6
PH - Filippine 6
RO - Romania 6
BR - Brasile 5
GR - Grecia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
IR - Iran 3
PL - Polonia 3
AR - Argentina 2
AT - Austria 2
BD - Bangladesh 2
EE - Estonia 2
ES - Italia 2
EU - Europa 2
KR - Corea 2
MX - Messico 2
PA - Panama 2
CZ - Repubblica Ceca 1
IS - Islanda 1
JP - Giappone 1
KZ - Kazakistan 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
UG - Uganda 1
VE - Venezuela 1
Totale 7.656
Salva come PNG Salva come JPEG
Città #
Chandler 1.207
Wilmington 1.051
San Mateo 402
Ann Arbor 337
Helsinki 336
New York 244
Dublin 235
Singapore 234
Boardman 206
Lawrence 204
Princeton 204
Benin City 191
Leawood 179
Shanghai 169
Paris 120
Ashburn 117
Fairfield 87
Woodbridge 82
Amsterdam 59
London 44
Pune 33
Milan 32
Norwalk 22
San Diego 18
Santa Clara 18
Seattle 17
Brussels 15
Lahore 14
Los Angeles 14
Phoenix 12
Toronto 11
Abbiategrasso 9
Falkenstein 9
Kocaeli 9
Skopje 8
Rome 7
Hanover 6
Monmouth Junction 6
Mumbai 6
Redmond 6
Beijing 5
Bitola 5
Clearwater 5
Falls Church 5
Moscow 5
Dronten 4
Frankfurt am Main 4
Houston 4
São Paulo 4
Andover 3
Budapest 3
Des Moines 3
Henderson 3
Many 3
Novokuznetsk 3
Olongapo City 3
Pavia 3
Prilep 3
Redwood City 3
Riverview 3
Apo 2
Athens 2
Brighton 2
Buenos Aires 2
Canberra 2
Cesano Boscone 2
Dhaka 2
Eden Prairie 2
Erbusco 2
Gdansk 2
Geneva 2
Genoa 2
Jerusalem 2
Kemerovo 2
Kochi 2
Las Pinas 2
Nanjing 2
Palazzolo sull'Oglio 2
Portland 2
Puebla 2
Sale Marasino 2
San Francisco 2
San Jose 2
Tallinn 2
Turi 2
Venegono Superiore 2
Washington 2
Addison 1
Adelaide 1
Agrate Brianza 1
Almaty 1
Bristol 1
Brno 1
Cagayan de Oro 1
Chicago 1
Chisinau 1
Dearborn 1
Durham 1
Ferrara 1
Florence 1
Totale 6.121
Salva come PNG Salva come JPEG
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 123
G protein mutations in endocrine diseases 66
A 2019 update on TSH-secreting pituitary adenomas 66
A Rare Case of Cushing Syndrome Caused by an Ectopic ACTH-Secreting Pancreatic Neuroendocrine Tumor in a Patient with Von Hipple-Lindau Disease 63
Parental origin of G(s)alpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors 62
Analysis of GNAS1 and PRKAR1A gene mutations in human cardiac myxomas not associated with multiple endocrine disorders 59
Growth factors and human pituitary adenomas 59
G-Protein and Signalling in Pituitary Tumours 58
A potential catastrophic trap: an unusually presenting sellar lesion 56
G protein abnormalities in pituitary adenomas 56
FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression 56
d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype 54
Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac) 54
Functional hypothalamic and drug-induced amenorrhea: an overview 53
Activating mutations of the G(s)alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors 53
The trans-sphenoidal resection of pituitary adenomas in elderly patients and surgical risk 53
Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients 52
Hormonal signaling and pituitary adenomas 52
Abacavir, nevirapine, and ritonavir modulate intracellular calcium levels without affecting GHRH-mediated growth hormone secretion in somatotropic cells in vitro 52
An Unusual Case of Recurrent Autoimmune Hypophysitis 51
Central hypothyroidism and growth hormone treatment : clinical care 50
Bone disorders associated with acromegaly: mechanisms and treatment 50
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas 50
Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation 50
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly 50
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 50
Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident 49
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma 49
Growth hormone replacement therapy in growth hormone deficient children and adults: Effects on hemochrome 48
Central hypothyroidism 48
A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal 48
Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients 48
Medullary thyroid carcinoma treated with percutaneous ultrasound-guided radiofrequency ablation 48
Central hypothyroidism - a neglected thyroid disorder 47
Different expression of protein kinase A (PKA) regulatory subunits in normal and neoplastic thyroid tissues 47
Adequacy of current postglucose GH nadir limit (< 1 mu g/1) to define long-lasting remission of acromegalic disease 47
Expression of the anti-apoptotic factor seladin-1 and induction of apoptosis in GH secreting adenomas and in non-functioning pituitary adenomas 47
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 47
Levothyroxine supplementation on assisted reproduction technology (ART) outcomes in women with subtle hypothyroidism: a retrospective study 47
Artificial intelligence-based radiomics on computed tomography of lumbar spine in subjects with fragility vertebral fractures 46
Filamin-A Is Essential for Dopamine D2 Receptor Expression and Signaling in Tumorous Lactotrophs 46
A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment 46
Genetics of pituitary tumors: Focus on G-protein mutations 45
cAMP in the pituitary: An old messenger for multiple signals 45
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients 45
Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas 44
Expression of calcium-sensing receptor and characterization of intracellular signaling in human pituitary adenomas 44
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells 44
Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands 44
Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours 44
Inactivating and activating mutations of the Gs alpha gene 44
Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of Disease 43
Pituitary incidentalomas 43
GNAS imprinting and pituitary tumors 43
Biallelic expression of the Gs alpha gene in human bone and adipose tissue 43
Growth Hormone Receptor Variants and Response to Pegvisomant in Monotherapy or in Combination with Somatostatin Analogs in Acromegalic Patients: A Multicenter Study 43
Effects of hypothalamic neuropeptides on extracellular signal-regulated kinase (ERK1 and ERK2) cascade in human tumoral pituitary cells 43
Endoscopic expanded endonasal approach: preliminary experience with the new 3D endoscope 43
Un caso di carcinoma neuroendocrino del timo determinante sindrome di Cushing da ACTH ectopico 43
Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors 43
High bone marrow fat in patients with Cushing's syndrome and vertebral fractures. 43
Effect of cyclic adenosine 3 ',5 '-monophosphate/protein kinase A pathway on markers of cell proliferation in nonfunctioning pituitary adenomas 43
GH Replacement Improves Quality of Life and Metabolic Parameters in Cured Acromegalic Patients with Growth Hormone Deficiency 43
Mechanisms of disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases 43
Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy 43
Expression of protein kinase A regulatory subunits in benign and malignant human thyroid tissues : a systematic review 42
Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia 42
The Number of Metastatic Lymph Nodes is a Useful Predictive Factor for Recurrence after Surgery for Nonmetastatic Nonfunctional Neuroendocrine Neoplasm of the Pancreas 42
High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells 42
Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function 42
Double Pituitary and Conserved Function in an Adult Patient with Neurofibromatosis Type 1 41
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors 41
Focus on GH deficiency and thyroid function 41
Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment 41
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 41
Correction to: Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 41
Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors 40
Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma 40
Evolution of an Aggressive Prolactinoma into a Growth Hormone Secreting Pituitary Tumor Coincident with GNAS Gene Mutation 40
GH Response to Oral Glucose Tolerance Test: A Comparison between Patients with Acromegaly and Other Pituitary Disorders 40
Constitutively active Gs alpha is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas 40
Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks 40
Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short- and long-term recombinant human GH replacement therapy 40
Identification of human somatostatin receptor 2 domains involved in internalization and signaling in QGP-1 pancreatic neuroendocrine tumor cell line 40
Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression 40
Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy 40
Thyrotoxicosis in patients with COVID-19: the THYRCOV study 40
Evaluation of proopiomelanocortin mRNA in the peripheral blood from patients with Cushing's syndrome of different origin 39
Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation 39
Low testosterone predicts hypoxemic respiratory insufficiency and mortality in patients with COVID-19 disease: another piece in the COVID puzzle 39
cAMP effects in neuroendocrine tumors: The role of Epac and PKA in cell proliferation and adhesion 38
Complete Remission of Hepatic Metastasis after Total Gastrectomy for a Gastric Carcinoid Tumor Type 1: A Case Report 38
Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly 38
Mutational analysis of PRKAR1A and Gs alpha in sporadic adrenocortical tumors 38
Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase A regulatory subunit 1A protein 38
Is the 250 mu g ACTH test a useful tool for the diagnosis of central hypoadrenalism in adult patients with pituitary disorders? 38
Impact of IGF(CA)19 gene polymorphism on the metabolic response to GH therapy in adult GH-deficient patients 38
The benefit of statins in SARS-CoV-2 patients: further metabolic and prospective clinical studies are needed 38
Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas 37
Growth hormone-releasing hexapeptide (GHRP-6) increases intracellular calcium concentrations in cultured cells from human pituitary adenomas of different types 37
Totale 4.648
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.738
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/20211.831 6 24 9 15 15 624 252 154 352 173 10 197
2021/20221.008 31 5 7 226 7 8 32 132 143 115 237 65
2022/20233.127 448 141 308 348 287 268 25 253 536 291 178 44
2023/20241.821 122 203 333 112 44 269 103 105 48 28 185 269
2024/202549 49 0 0 0 0 0 0 0 0 0 0 0
Totale 7.837